Home › Funds › PFIZER INC › AGMB

PFIZER INC position in AGMB

Agomab Therapeutics NV · Health Care

PFIZER INC reported holding 2,151,213 shares of AGMB (Agomab Therapeutics NV) in its Q3 2026 13F filing — a position valued at US$22.6M, representing 13.77% of its reported portfolio and ranking #4 among its reported holdings. PFIZER INC has disclosed AGMB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)2.15M sh
Reported value held$22.61M
Portfolio Weight13.77%
First reportedQ1 2026
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How PFIZER INC's AGMB position evolved

PFIZER INC first disclosed a stake in AGMB in Q1 2026 at 75,000 shares (US$814K). The position peaked in Q3 2026 at 2,151,213 shares, worth US$22.6M. Across 3 filings, PFIZER INC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,151,213 shares valued at US$22.6M — an increase of 2,076,213 shares quarter over quarter.. Notable position changes include a 2768% increase in Q3 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 75.00K $813.75K New
Q2 2026 75.00K $1.04M Hold
Q3 2026 2.15M $22.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AGMB and 13F data

AGMB (Agomab Therapeutics NV) is a Health Care company. 34 other funds we track also report a position in AGMB — the largest reported positions include EQT Fund Management S.a r.l. (US$57.1M), Redmile Group, LLC (US$35.5M), Cormorant Asset Management, LP (US$32.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AGMB

All AGMB fund holders →

FAQ

How long has PFIZER INC held AGMB?

PFIZER INC has disclosed AGMB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is PFIZER INC's current position in AGMB?

As of Q3 2026, PFIZER INC holds 2.15M shares of AGMB (Agomab Therapeutics NV), valued at $22.61M, representing 13.77% of its reported portfolio and ranking #4.

Has PFIZER INC been buying or selling AGMB?

In the latest 13F filing (Q3 2026), PFIZER INC increased its position in AGMB. The position peaked in Q3 2026 at 2.15M shares.

Which other funds hold AGMB?

Other major institutional holders of AGMB include EQT Fund Management S.a r.l., Redmile Group, LLC, Cormorant Asset Management, LP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.